Abstract
We performed retrospective review of 29 adult patients with cerebellar medulloblastoma/primitive neuroectodermal tumor (PNET) who received craniospinal radiotherapy in Ankara Oncology Hospital between years 2000 and 2005. All patients were operated followed by craniospinal irradiation; 11 of 29 patients also received chemotherapy. All patients had no distant or spinal metastases at the time of diagnosis. Median follow up time was 26 months. Progression-free survival was 86% at 2 years, 55% at 5 years. Mean progression-free survival was 25 months in patients with PNET; 61.4 months in patients with medulloblastoma (P = 0.0016). Mean survival was 61.33% months in patients <25 age, 38 months in patients >25 age. (P = 0.04). Overall mean survival was 59.80 months in patients who received chemotherapy and 41.4 months in patients who did not have chemotherapy (P = 0.15). Cranial relapses were observed in 3 of 29 patients, and 3 of 29 patients had distant metastases. The mean time to cranial recurrence was 19 months; to distant metastases was 18 months. In conclusion, adult patients with PNET have worse survival rates than patients with medulloblastoma, like in childhood patients. Patients younger than 25 years of age also had statistically significant better survival.
Similar content being viewed by others
References
Prados MD, et al. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995;32:1145–52.
Le QT, et al. Adult medulloblastoma: an analysis of survival and prognostic factors. Cancer J Sci Am 1997;3:238–45.
Frost PJ, Laperriere NJ, Wong CS, et al. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995;32:951–7.
Carrie C, et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma: Retrospective study of 156 patients. Cancer 1994;74:2352–60.
Kunschner LJ, et al. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neurooncol 2001;3:167–73.
Chan AW, et al. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 2000;47:623–31, discussion 631–2.
Duffner PK, Cohen ME, Heffner RR, Freeman AI. Primitive neuroectodermal tumors of childhood. An approach to therapy. J Neurosurg 1981;55:376–81.
Jeskin D. Primitive neuroectodermal tumor In: Humprey GB, Dehner LP, editors. Pediatric Oncology. I. The Hague: Martmus Nijhoff; 1981. p. 243.
Gaffney CC, Sloane JP, Bradley NJ, Bloom HJG. PNET of the cerebrum: pathology and treatment. J Neurooncology 1985; 3:23–33.
Kosnik EJ, Boesel CP, Bay J, Sayers MP. PNET of the central nervous system in children. J Neurosurg 1978;48:741–6.
Zeltzer PM, et al. Prognostic factors for survival differ in high risk infra and supratentorial PNET [Abstract]. Pediatr Neurosurg 1993;19:333.
Herrlinger U, et al. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 2005;252:291–9.
Tabori U, et al. Distinctive clinical course and pattern of releps in adolescents with medulloblastoma. Int J Radiat Oncol Biol Phys 2006;64:402–7.
Spreafico F, Massimino M, Gandola L. Survival of adults treated for medulloblastoma using paediatric protocols. Eur J Cancer 2005;41:1304–10.
Brandes AA, et al. The treatment of adults with medulloblastoma: a prospective study. Int J Radiat Oncol Biol Phys 2003;57:755–61.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ertas, G., Ucer, A.R., Altundag, M.B. et al. Medulloblastoma/primitive neuroectodermal tumor in adults: prognostic factors and treatment results: a single-center experience from Turkey. Med Oncol 25, 69–72 (2008). https://doi.org/10.1007/s12032-007-0044-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-007-0044-6